Inflammaging is driven by upregulation of innate immune receptors and systemic interferon signaling and is ameliorated by dietary restriction.

CP: Immunology Stat1 aging chromatin accessibility dietary restriction epigenetics inflammaging inflammation interferon multi-tissue transcriptional network

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
28 06 2022
Historique:
received: 24 12 2020
revised: 28 03 2022
accepted: 07 06 2022
entrez: 29 6 2022
pubmed: 30 6 2022
medline: 2 7 2022
Statut: ppublish

Résumé

Aging is characterized by a chronic low-grade inflammation known as inflammaging in multiple tissues, representing a risk factor for age-related diseases. Dietary restriction (DR) is the best-known non-invasive method to ameliorate aging in many organisms. However, the molecular mechanism and the signaling pathways that drive inflammaging across different tissues and how they are modulated by DR are not yet understood. Here we identify a multi-tissue gene network regulating inflammaging. This network is characterized by chromatin opening and upregulation in the transcription of innate immune system receptors and by activation of interferon signaling through interferon regulatory factors, inflammatory cytokines, and Stat1-mediated transcription. DR ameliorates aging-induced alterations of chromatin accessibility and RNA transcription of the inflammaging gene network while failing to rescue those alterations on the rest of the genome. Our results present a comprehensive understanding of the molecular network regulating inflammation in aging and DR and provide anti-inflammaging therapeutic targets.

Identifiants

pubmed: 35767948
pii: S2211-1247(22)00806-3
doi: 10.1016/j.celrep.2022.111017
pii:
doi:

Substances chimiques

Chromatin 0
Receptors, Immunologic 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111017

Informations de copyright

Copyright © 2022 Leibniz Institute on Aging - Fritz Lipmann Institute. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Seyed Mohammad Mahdi Rasa (SMM)

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.

Francesco Annunziata (F)

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.

Anna Krepelova (A)

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany; Department of Life Sciences and Systems Biology, University of Torino, Torino, Italy.

Suneetha Nunna (S)

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.

Omid Omrani (O)

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.

Nadja Gebert (N)

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.

Lisa Adam (L)

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.

Sandra Käppel (S)

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.

Sven Höhn (S)

School of Bioscience, Cardiff University, Cardiff CF10 3AX, UK.

Giacomo Donati (G)

Department of Life Sciences and Systems Biology, University of Torino, Torino, Italy.

Tomasz Piotr Jurkowski (TP)

School of Bioscience, Cardiff University, Cardiff CF10 3AX, UK.

Karl Lenhard Rudolph (KL)

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.

Alessandro Ori (A)

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.

Francesco Neri (F)

Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany; Department of Life Sciences and Systems Biology, University of Torino, Torino, Italy. Electronic address: francesco.neri@unito.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH